Publications

This communique is published following each meeting of the MBS Review Advisory Committee (MRAC). It summarises the meeting outcomes, progress on current reviews and advice about upcoming reviews.

The First Interim Report provides early insights into the operations of the Medicare Urgent Care Clinics Program.

This report presents the results of the project that compared a low intensity cardiovascular disease risk assessment with a comprehensive one by community pharmacists.

The quarterly communique is published following each meeting of the MBS Review Advisory Committee (MRAC). It summarises the meeting outcomes, progress on current reviews and advice about upcoming reviews.

This report contains the key findings from the Surgical Assistant Working Group (SAWG).

This report contains the key findings from the Genetic Counselling Working Group (GCWG).

The quarterly communique is published following each meeting of the MBS Review Advisory Committee (MRAC). It summarises the meeting outcomes, progress on current reviews and advice about upcoming reviews.

This report presents the results of the project to trial a pharmacist-led support service for patients who take medication to manage chronic pain.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Intensive Care and Emergency Medicine Clinical Committee report.

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Diagnostic Clinical Committee PE/DVT report.

This newsletter outlines recent changes to the Medicare Benefits Schedule (MBS) as a result of the MBS Review.

This report presents the results of the project that compared a pharmacist-led early intervention to usual care in residential aged care facilities.

This report presents the results of the project trialling the use of community pharmacists' skills to help people get their asthma under control.

This fact sheet outlines recent changes to Medicare-funded neurosurgery and neurology services. These changes support best practice treatment and improve patient safety, and represent the Government’s response to recommendations made by the MBS Review Taskforce.

This document outlines the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Blood Products Working Group Report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government following its review of Thoracic Surgery MBS items.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Specialist and Consultant Physician Consultation Clinical Committee (SCPCCC) report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Gynaecology MBS items.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's recommendations on telehealth, including supporting information and rationale.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the General Practice and Primary Care Clinical Committee (GPPCCC) report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Vascular Services MBS items.

This document outlines the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Diagnostic Medicine Clinical Committee (DMCC) report.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of MBS items related to Specialist and Consultant Physicians.

This report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Paediatric Surgery MBS items.

This document summarises the Medicare Benefits Schedule (MBS) Taskforce’s recommendations in response to the Wound Management Working Group (WMWG) report.